Daniel M Junius - Net Worth and Insider Trading
Daniel M Junius Net Worth
The estimated net worth of Daniel M Junius is at least $7 Million dollars as of 2024-04-27. Daniel M Junius is the Director of Immunogen Inc and owns about 184,987 shares of Immunogen Inc (IMGN) stock worth over $6 Million. Daniel M Junius is the Director of IDEXX Laboratories Inc and owns about 2,982 shares of IDEXX Laboratories Inc (IDXX) stock worth over $1 Million. Daniel M Junius is also the Director of GlycoMimetics Inc and owns about 93,250 shares of GlycoMimetics Inc (GLYC) stock worth over $152,930. Details can be seen in Daniel M Junius's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel M Junius has not made any transactions after 2023-05-10 and currently still holds the listed stock(s).
Transaction Summary of Daniel M Junius
Daniel M Junius Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel M Junius owns 4 companies in total, including IDEXX Laboratories Inc (IDXX) , GlycoMimetics Inc (GLYC) , and Immunogen Inc (IMGN) among others .
Click here to see the complete history of Daniel M Junius’s form 4 insider trades.
Insider Ownership Summary of Daniel M Junius
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IDXX | IDEXX Laboratories Inc | 2023-04-28 | director |
| GLYC | GlycoMimetics Inc | 2023-05-10 | director |
| IMGN | Immunogen Inc | 2018-03-16 | Chief Financial Officer |
| VTAE | Vitae Pharmaceuticals Inc | 2016-10-25 | director |
Daniel M Junius Latest Holdings Summary
Daniel M Junius currently owns a total of 3 stocks. Among these stocks, Daniel M Junius owns 184,987 shares of Immunogen Inc (IMGN) as of March 16, 2018, with a value of $6 Million and a weighting of 77.87%. Daniel M Junius owns 2,982 shares of IDEXX Laboratories Inc (IDXX) as of February 16, 2023, with a value of $1 Million and a weighting of 20.07%. Daniel M Junius also owns 93,250 shares of GlycoMimetics Inc (GLYC) as of May 10, 2023, with a value of $152,930 and a weighting of 2.06%.
Latest Holdings of Daniel M Junius
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IMGN | Immunogen Inc | 2018-03-16 | 184,987 | 31.23 | 5,777,144 |
| IDXX | IDEXX Laboratories Inc | 2023-02-16 | 2,982 | 499.30 | 1,488,913 |
| GLYC | GlycoMimetics Inc | 2023-05-10 | 93,250 | 1.64 | 152,930 |
Holding Weightings of Daniel M Junius
Daniel M Junius Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel M Junius has made a total of 0 transactions in Immunogen Inc (IMGN) over the past 5 years. The most-recent trade in Immunogen Inc is the sale of 25,000 shares on March 16, 2018, which brought Daniel M Junius around $300,500.
According to the SEC Form 4 filings, Daniel M Junius has made a total of 6 transactions in IDEXX Laboratories Inc (IDXX) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in IDEXX Laboratories Inc is the sale of 2,187 shares on February 16, 2023, which brought Daniel M Junius around $1 Million.
According to the SEC Form 4 filings, Daniel M Junius has made a total of 4 transactions in GlycoMimetics Inc (GLYC) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in GlycoMimetics Inc is the acquisition of 30,000 shares on May 10, 2023, which cost Daniel M Junius around $46,800.
Insider Trading History of Daniel M Junius
- 1
Daniel M Junius Trading Performance
GuruFocus tracks the stock performance after each of Daniel M Junius's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel M Junius is 12.14%. GuruFocus also compares Daniel M Junius's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel M Junius within 3 months outperforms 6 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel M Junius's insider trading performs compared to the benchmark.
Performance of Daniel M Junius
Average Return
28.48%
Outperforming Transactions
78%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.56 | 12.14 | -0.07 | 28.48 | 14.6 | 10.58 |
| Relative Return to S&P 500(%) | 4.55 | 7.84 | -2.88 | 22.63 | 14.9 | 8.95 |
Daniel M Junius Ownership Network
Ownership Network List of Daniel M Junius
Ownership Network Relation of Daniel M Junius
Daniel M Junius Owned Company Details
What does IDEXX Laboratories Inc do?
Who are the key executives at IDEXX Laboratories Inc?
Daniel M Junius is the director of IDEXX Laboratories Inc. Other key executives at IDEXX Laboratories Inc include Corporate Vice President James F Polewaczyk , CORPORATE VICE PRESIDENT George Fennell , and director & President and CEO Jonathan Jay Mazelsky .
IDEXX Laboratories Inc (IDXX) Insider Trades Summary
Over the past 18 months, Daniel M Junius made 2 insider transaction in IDEXX Laboratories Inc (IDXX) with a net sale of 5,233. Other recent insider transactions involving IDEXX Laboratories Inc (IDXX) include a net sale of 56,282 shares made by Jonathan Jay Mazelsky , a net sale of 20,887 shares made by Kathy V Turner , and a net sale of 42,649 shares made by James F Polewaczyk .
In summary, during the past 3 months, insiders sold 53,032 shares of IDEXX Laboratories Inc (IDXX) in total and bought 0 shares, with a net sale of 53,032 shares. During the past 18 months, 200,425 shares of IDEXX Laboratories Inc (IDXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 200,425 shares.
IDEXX Laboratories Inc (IDXX)'s detailed insider trading history can be found in Insider Trading Tracker table.
IDEXX Laboratories Inc Insider Transactions
Daniel M Junius Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel M Junius. You might contact Daniel M Junius via mailing address: C/o Immunogen, Inc., 830 Winter Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
